Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

[Effect of the selective ligands 5-HT(1A) receptors administration on the impulsive and self-control behavior in rats].

Zaĭchenko MI, Merzhanova GKh, Vanetsian GL.

Zh Vyssh Nerv Deiat Im I P Pavlova. 2012 Jul-Aug;62(4):465-74. Russian.

PMID:
23035563
3.

Receptor-genes cross-talk: effect of chronic 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino) tetralin treatment on the expression of key genes in brain serotonin system and on behavior.

Popova NK, Naumenko VS, Cybko AS, Bazovkina DV.

Neuroscience. 2010 Aug 11;169(1):229-35. doi: 10.1016/j.neuroscience.2010.04.044. Epub 2010 Apr 25.

PMID:
20423722
4.

Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.

Zhang H, Wang W, Jiang Z, Shang J, Zhang L.

Arzneimittelforschung. 2010;60(3):109-15. doi: 10.1055/s-0031-1296258.

PMID:
20422941
5.

Involvement of the 5-HT1A receptors in classical fear conditioning in C57BL/6J mice.

Stiedl O, Misane I, Spiess J, Ogren SO.

J Neurosci. 2000 Nov 15;20(22):8515-27.

6.
7.

Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.

Wesołowska A, Paluchowska MH, Gołembiowska K, Chojnacka-Wójcik E.

J Pharm Pharmacol. 2003 Apr;55(4):533-43.

PMID:
12803776
8.

8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.

Hedlund PB, Kelly L, Mazur C, Lovenberg T, Sutcliffe JG, Bonaventure P.

Eur J Pharmacol. 2004 Mar 8;487(1-3):125-32.

PMID:
15033384
9.

Pharmacological studies of 8-OH-DPAT-induced pupillary dilation in anesthetized rats.

Yu Y, Ramage AG, Koss MC.

Eur J Pharmacol. 2004 Apr 12;489(3):207-13.

PMID:
15087245
10.

Single exposure to a serotonin 1A receptor agonist, (+)8-hydroxy-2-(di-n-propylamino)-tetralin, produces a prolonged heterologous desensitization of serotonin 2A receptors in neuroendocrine neurons in vivo.

Carrasco GA, Van de Kar LD, Jia C, Xu H, Chen Z, Chadda R, Garcia F, Muma NA, Battaglia G.

J Pharmacol Exp Ther. 2007 Mar;320(3):1078-86. Epub 2006 Dec 11.

11.
12.

5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.

De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.

Eur Neuropsychopharmacol. 2004 Dec;14(6):487-95.

PMID:
15589388
13.
14.

Mapping of CBV changes in 5-HT(1A) terminal fields by functional MRI in the mouse brain.

Mueggler T, Razoux F, Russig H, Buehler A, Franklin TB, Baltes C, Mansuy IM, Rudin M.

Eur Neuropsychopharmacol. 2011 Apr;21(4):344-53. doi: 10.1016/j.euroneuro.2010.06.010. Epub 2010 Jul 24.

PMID:
20656461
15.

Activation of 5-hydroxytryptamine-1A receptors suppresses cardiovascular responses evoked from the paraventricular nucleus.

Horiuchi J, Atik A, Iigaya K, McDowall LM, Killinger S, Dampney RA.

Am J Physiol Regul Integr Comp Physiol. 2011 Oct;301(4):R1088-97. doi: 10.1152/ajpregu.00144.2011. Epub 2011 Jul 13.

16.

8-Hydroxy-2-(di-n-propylamino)-tetralin inhibits food intake in fasted rats by an action at 5-HT1A receptors.

Ebenezer IS, Arkle MJ, Tite RM.

Methods Find Exp Clin Pharmacol. 2007 May;29(4):269-72.

PMID:
17609739
17.

Bidirectional modulation of classical fear conditioning in mice by 5-HT(1A) receptor ligands with contrasting intrinsic activities.

Youn J, Misane I, Eriksson TM, Millan MJ, Ogren SO, Verhage M, Stiedl O.

Neuropharmacology. 2009 Oct-Nov;57(5-6):567-76. doi: 10.1016/j.neuropharm.2009.07.011. Epub 2009 Jul 15.

PMID:
19607850
18.

WAY100635 blocks the hypophagia induced by 8-OH-DPAT in the hypothalamic nuclei.

Steffens SM, Beckman D, Faria MS, Marino-Neto J, Paschoalini MA.

Physiol Behav. 2010 Apr 19;99(5):632-7. doi: 10.1016/j.physbeh.2010.01.024. Epub 2010 Feb 6.

PMID:
20138904
19.

The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.

Guenther U, Manzke T, Wrigge H, Dutschmann M, Zinserling J, Putensen C, Hoeft A.

Anesth Analg. 2009 Apr;108(4):1169-76. doi: 10.1213/ane.0b013e318198f828.

PMID:
19299781
20.

Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.

Hughes ZA, Starr KR, Langmead CJ, Hill M, Bartoszyk GD, Hagan JJ, Middlemiss DN, Dawson LA.

Eur J Pharmacol. 2005 Mar 7;510(1-2):49-57.

PMID:
15740724

Supplemental Content

Support Center